RKIP suppresses gastric cancer cell proliferation and invasion and enhances apoptosis regulated by microRNA-224

Tumor Biology

Volumn 35, Issue 10, 2014, Pages 10095-10103

  Liu, Hongyi ^a   Li, Peng ^a   Li, Bing ^a   Sun, Peng ^a   Zhang, Jiajin ^a   Wang, Baishi ^a   Jia, Baoqing ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Apoptosis; Gastric cancer; miR 224; Proliferation; RKIP

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; MICRORNA; MICRORNA 224; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; UNCLASSIFIED DRUG; MIRN224 MICRORNA, HUMAN; PEBP1 PROTEIN, HUMAN; TRANSCRIPTOME;

APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; EXPRESSION VECTOR; FLOW CYTOMETRY; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH CARCINOGENESIS; WESTERN BLOTTING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; TUMOR INVASION;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TRANSCRIPTOME;

EID: 84921325331     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2303-4     Document Type: Article

References (43)

1. Hu B, El Hajj N, Sittler S, Lammert N, Barnes R, Meloni- Ehrig A. Gastric cancer: classification, histology and application of molecular pathology. J Gastrointest Oncol. 2012;3(3): 251-61.
2. Bu Z, Ji J. Controversies in the diagnosis and management of early gastric cancer. Chin J Cancer Res. 2013;25(3):263-6.
3. Ryu KW, SENORITA Study Group. Future perspective of laparoscopic surgery for gastric cancer: sentinel node navigation functionpreserving surgery for early gastric cancer. Transl Gastrointest Cancer. 2013;2(3):160-3.
4. Ling TC, Kang JI, Slater JD, Yang GY. Proton therapy for gastrointestinal cancers. Transl Cancer Res. 2012;1(3):150-8.
5. Wang YX, Wang DW, Zhu XM, Zhao F, Leung KC. Carbon coated superparamagnetic iron oxide nanoparticles for sentinel lymph nodes mapping. Quant Imaging Med Surg. 2012;2:53-6.
6. SmithHS. Painful boneymetastases.Ann PalliatMed. 2012;1(1):14- 31.
7. Kang B, Sun XH. Regulation of cancer stem cells by RING finger ubiquitin ligases. Stem Cell Investig. 2014;1:5.
8. Gotoda T, Kusano C, Moriyasu F. Future perspective of gastric cancer endotherapy. Ann Transl Med. 2014;2(3):25.
9. Achyut BR, Yang L. Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment. Gastroenterology. 2011;141(4):1167-78.
10. St Hill CA. Interactions between endothelial selectins and cancer cells regulate metastasis. Front Biosci. 2011;17:3233-51.
11. Ali AS, Ahmad A, Ali S, Bao B, Philip PA, Sarkar FH. The role of cancer stem cells and miRNAs in defining the complexities of brain metastasis. J Cell Physiol. 2013;228(1):36-42.
12. Yamada Y. Molecular therapy for gastric cancer. Chin Clin Oncol. 2013;2(1):5.
13. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. microRNAs in cancer management. Lancet Oncol. 2012;13(6): e249-58.
14. Gigek CO, Chen ES, Calcagno DQ,Wisnieski F, Burbano RR, Smith MA. Epigenetic mechanisms in gastric cancer. Epigenomics. 2012;4(3):279-94.
15. Li JH, Zhang SW, Liu J, Shao MZ, Chen L. Review of clinical investigation on recurrence of gastric cancer following curative resection. Chin Med J (Engl). 2012;125(8):1479-95.
16. Bijelic L, Sugarbaker PH. The role of intraperitoneal chemotherapy in the treatment of patients with advanced gastric cancer. Ann Ital Chir. 2012;83(3):224-31.
17. Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature. 1999;401(6749):173-7.
18. Zeng L, Imamoto A, Rosner MR. Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Expert Opin Ther Targets. 2008;12(10):1275-87.
19. Granovsky AE, Rosner MR. Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell Res. 2008;18(4):452-7.
20. Khamis ZI, Iczkowski KA, Sang QX. Metastasis suppressors in human benign prostate, intraepithelial neoplasia, and invasive cancer: their prospects as therapeutic agents. Med Res Rev. 2012;32(5): 1026-77.
21. Morecroft I, Doyle B, Nilsen M, Kolch W, Mair K, Maclean MR. Mice lacking the Raf-1 kinase inhibitor protein exhibit exaggerated hypoxia-induced pulmonary hypertension. Br J Pharmacol. 2011;163(5):948-63.
22. Beshir AB, Ren G,Magpusao AN, Barone LM, Yeung KC, Fenteany G. Raf kinase inhibitor protein suppresses nuclear factor-κBdependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. Cancer Lett. 2010;299(2):137-49.
23. Fu Z, Smith PC, Zhang L, RubinMA, Dunn RL, Yao Z, et al. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst. 2003;95(12):878-89.
24. Xu YF, Yi Y, Qiu SJ, Gao Q, Li YW, Dai CX, et al. PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection. J Hepatol. 2010;53(5):872-9.
25. Lin K, Baritaki S, Militello L,Malaponte G, Bevelacqua Y, Bonavida B. The role of B-RAF mutations in melanoma and the induction of EMT via dysregulation of the NF-κB/Snail/RKIP/PTEN Circuit. Genes Cancer. 2010;1(5):409-20.
26. Al-Mulla F, Hagan S, Al-Ali W, Jacob SP, Behbehani AI, Bitar MS, et al. Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability. J Clin Pathol. 2008;61(4): 524-9.
27. Li HZ, Gao Y, Zhao XL, Liu YX, Sun BC, Yang J, et al. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer. Mol Cancer Res. 2009;7(6):832-40.
28. Minn AJ, Bevilacqua E, Yun J, Rosner MR. Identification of novel metastasis suppressor signaling pathways for breast cancer. Cell Cycle. 2012;11(13):2452-7.
29. Bonavida B, Baritaki S. The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry. Crit Rev Oncog. 2011;16(3-4):211-26.
30. Cheng J, Fan XM. Role of cyclooxygenase-2 in gastric cancer development and progression. World J Gastroenterol. 2013;19(42): 7361-8.
31. Nakamura S, Matsumoto T. Helicobacter pylori and gastric mucosaassociated lymphoid tissue lymphoma: recent progress in pathogenesis and management. World J Gastroenterol. 2013;19(45):8181-7.
32. Sarvaiya PJ, Guo D,Ulasov I,Gabikian P, Lesniak MS. Chemokines in tumor progression and metastasis. Oncotarget. 2013;4(12):2171-85.
33. He C, Chen M, Liu J, Yuan Y. Host genetic factors respond to pathogenic step-specific virulence factors of Helicobacter pylori in gastric carcinogenesis. Mutat Res Rev Mutat Res. 2014;759:14-26.
34. Al-Mulla F, BitarMS, Taqi Z, Yeung KC. RKIP:muchmore than Raf kinase inhibitory protein. J Cell Physiol. 2013;228(8):1688-702.
35. Escara-Wilke J, Yeung K, Keller ET. Raf kinase inhibitor protein (RKIP) in cancer. Cancer Metastasis Rev. 2012;31(3-4):615-20.
36. Link A, Kupcinskas J, Wex T, Malfertheiner P. Macro-role of microRNA in gastric cancer. Dig Dis. 2012;30(3):255-67.
37. Wang X, Cao L, Wang Y, Liu N, You Y. Regulation of let-7 and its target oncogenes (review). Oncol Lett. 2012;3(5):955-60.
38. Zhou X, Yuan P, He Y. Role of microRNAs in peripheral artery disease (review). Mol Med Rep. 2012;6(4):695-700.
39. Ui-Tei K, Nishi K, Takahashi T, Nagasawa T. Thermodynamic control of small RNA-mediated gene silencing. Front Genet. 2012;3:101.
40. Yang JS, Maurin T, Lai EC. Functional parameters of Dicerindependent microRNA biogenesis. RNA. 2012;18(5):945-57.
41. Weiland M, Gao XH, Zhou L, Mi QS. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol. 2012;9(6).
42. Du L, Pertsemlidis A. microRNA regulation of cell viability and drug sensitivity in lung cancer. Expert Opin Biol Ther. 2012;12(9):1221-39.
43. Yamamoto H, Adachi Y, Taniguchi H, Kunimoto H, Nosho K, Suzuki H, et al. Interrelationship between microsatellite instability and microRNA in gastrointestinal cancer. World J Gastroenterol. 2012;18(22):2745-55.